HYPOG - Overview: Hypoglycemic Agent Screen, Serum

Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...

IMIPR - Overview: Imipramine and Desipramine, Serum

Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance

FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine

Detection and confirmation of illicit drug use involving fentanyl

ALCX - Overview: Ethanol, Chain of Custody, Blood

Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication All testing is performed...

FENR - Overview: Fentanyl Screen with Reflex, Random, Urine

Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen

ETGSR - Overview: Ethyl Glucuronide Screen with Reflex, Random, Urine

Screening for drug abuse involving alcohol

PBUCR - Overview: Lead/Creatinine Ratio, Random, Urine

Detecting clinically significant lead exposure, a toxic heavy metal, using random urine specimens

PBU - Overview: Lead, 24 Hour, Urine

Detecting clinically significant lead exposure in 24-hour specimens This test is not a substitute for blood lead screening.

KI67P - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Automated

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases

LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine

Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.